
Active Pharmaceutical Ingredients Market (API) by Type (Generic Active Pharmaceutical Ingredients, Innovative Active Pharmaceutical Ingredients), Synthesis (Biotech Active Pharmaceutical Ingredients, Synthetic Active Pharmaceutical Ingredients), Manufactu
Description
Active Pharmaceutical Ingredients Market (API) by Type (Generic Active Pharmaceutical Ingredients, Innovative Active Pharmaceutical Ingredients), Synthesis (Biotech Active Pharmaceutical Ingredients, Synthetic Active Pharmaceutical Ingredients), Manufacturer, Therapeutic Application - Global Forecast 2024-2030
The Active Pharmaceutical Ingredients Market size was estimated at USD 227.01 billion in 2023 and expected to reach USD 241.99 billion in 2024, at a CAGR 6.69% to reach USD 357.27 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Active Pharmaceutical Ingredients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Active Pharmaceutical Ingredients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Active Pharmaceutical Ingredients Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., API Pharma Tech, AstraZeneca plc, Aurobindo Pharma Limited, BASF SE, BDR Pharmaceuticals Internationals Pvt. Ltd., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Cipla, Inc., Dr. Reddy's Laboratories Ltd, ELI Lilly and Company, F. Hoffmann-La Roche AG, Glaxosmithkline PLC, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.
Market Segmentation & Coverage
This research report categorizes the Active Pharmaceutical Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Generic Active Pharmaceutical Ingredients
Biotech Active Pharmaceutical Ingredients
Captive API Manufacturers
Cardiovascular Diseases
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Active Pharmaceutical Ingredients Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Active Pharmaceutical Ingredients Market?
- What are the technology trends and regulatory frameworks in the Active Pharmaceutical Ingredients Market?
- What is the market share of the leading vendors in the Active Pharmaceutical Ingredients Market?
- Which modes and strategic moves are suitable for entering the Active Pharmaceutical Ingredients Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
190 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Active Pharmaceutical Ingredients Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing importance of generics coupled with uptakes of biopharmaceuticals
- 5.1.1.2. Technological advancements in active pharmaceutical ingredients
- 5.1.1.3. Adoption of AI-based tools and organ-on-chip models in drug discovery & development
- 5.1.2. Restraints
- 5.1.2.1. Unsupportive price control policies for drug across various countries
- 5.1.2.2. Increasing availability of counterfeit drugs
- 5.1.3. Opportunities
- 5.1.3.1. Emergence of biosimilars
- 5.1.3.2. Highly effective active pharmaceutical ingredients
- 5.1.4. Challenges
- 5.1.4.1. High cost associated with the manufacturing process
- 5.1.4.2. Concern associated with the product differentiation
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Active Pharmaceutical Ingredients Market, by Type
- 6.1. Introduction
- 6.2. Generic Active Pharmaceutical Ingredients
- 6.3. Innovative Active Pharmaceutical Ingredients
- 7. Active Pharmaceutical Ingredients Market, by Synthesis
- 7.1. Introduction
- 7.2. Biotech Active Pharmaceutical Ingredients
- 7.3. Synthetic Active Pharmaceutical Ingredients
- 8. Active Pharmaceutical Ingredients Market, by Manufacturer
- 8.1. Introduction
- 8.2. Captive API Manufacturers
- 8.3. Merchant API Manufacturers
- 9. Active Pharmaceutical Ingredients Market, by Therapeutic Application
- 9.1. Introduction
- 9.2. Cardiovascular Diseases
- 9.3. Communicable Diseases
- 9.4. Diabetes
- 9.5. Oncology
- 9.6. Pain Management
- 9.7. Respiratory Diseases
- 10. Americas Active Pharmaceutical Ingredients Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Active Pharmaceutical Ingredients Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Active Pharmaceutical Ingredients Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbvie Inc.
- 14.1.2. API Pharma Tech
- 14.1.3. AstraZeneca plc
- 14.1.4. Aurobindo Pharma Limited
- 14.1.5. BASF SE
- 14.1.6. BDR Pharmaceuticals Internationals Pvt. Ltd.
- 14.1.7. Bristol-Myers Squibb Company
- 14.1.8. C.H. Boehringer Sohn AG & Co. KG
- 14.1.9. Cipla, Inc.
- 14.1.10. Dr. Reddy's Laboratories Ltd
- 14.1.11. ELI Lilly and Company
- 14.1.12. F. Hoffmann-La Roche AG
- 14.1.13. Glaxosmithkline PLC
- 14.1.14. Merck & Co., Inc.
- 14.1.15. Mylan N.V.
- 14.1.16. Novartis AG
- 14.1.17. Pfizer, Inc.
- 14.1.18. Sanofi S.A.
- 14.1.19. Sun Pharmaceutical Industries Ltd
- 14.1.20. Teva Pharmaceutical Industries Ltd
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
- FIGURE 2. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DYNAMICS
- FIGURE 7. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2023 VS 2030 (%)
- FIGURE 10. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2023 VS 2030 (%)
- FIGURE 12. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.